Dyslexia is a neurodevelopmental disorder that can be diagnosed as early as the end of first grade, thanks to behavioral assessments. However, neurophysiological markers (biomarkers) could enable early detection of children at risk of developing this specific learning disorder. These various EEG biomarkers, once adjusted to clinical constraints, could constitute reliable tools to assist healthcare professionals in the early detection of dyslexia or other neurodevelopmental disorders. They also open up new prospects in the development of digital tools for early diagnosis and remediation.